Maxcyte, INC. (MXCT) SEC Filings — 2024
22 SEC filings for Maxcyte, INC. (MXCT) in 2024.
Filings
- MaxCyte Appoints New Chief Medical Officer — 8-K · Dec 27, 2024
- MaxCyte, Inc. Files 8-K on Exit Costs — 8-K · Dec 9, 2024
- Maxcyte, INC. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Maxcyte, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- MaxCyte, Inc. Files 8-K on Financials — 8-K · Nov 6, 2024
- Maxcyte, INC. SC 13G/A Filing — SC 13G/A · Oct 31, 2024
- Maxcyte, INC. SC 13G/A Filing — SC 13G/A · Oct 21, 2024
- MaxCyte Appoints New Chief Medical Officer — 8-K · Oct 15, 2024
- MaxCyte, Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 6, 2024
- MaxCyte Elects New Directors, Stockholder Proposals Approved — 8-K · Jun 12, 2024
- MaxCyte, Inc. Files 8-K on Financials — 8-K · May 7, 2024
- MaxCyte, Inc. Announces 2024 Annual Meeting of Stockholders on June 11 — DEF 14A · Apr 26, 2024
- Maxcyte, INC. SC 13G Filing — SC 13G · Mar 25, 2024
- MaxCyte, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 12, 2024
- MaxCyte Files 8-K on Operations and Financials — 8-K · Mar 5, 2024
- Maxcyte, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Maxcyte, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Maxcyte, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Millennium's Integrated Core Strategies Files Amended 13G/A on MAXCYTE — SC 13G/A · Feb 1, 2024
- BlackRock Amends MAXCYTE Stake Filing as of Dec 31, 2023 — SC 13G/A · Jan 26, 2024
- MAXCYTE 8-K: Officer/Director Changes & Comp Arrangements — 8-K · Jan 26, 2024
- MAXCYTE Files 8-K on Financial Condition & Operations — 8-K · Jan 8, 2024